Complement-fixing antigen of human cytomegaloviruses
- PMID: 190330
- DOI: 10.1093/infdis/135.2.281
Complement-fixing antigen of human cytomegaloviruses
Abstract
The titer of complement-fixing (CF) antigen of human cytomegalovirus (CMV) strain C87 was not reduced by 10 cycles of freezing and thawing or by storage at 4 C for two months, although the virus was labile at 37 C and 100 C. The rapid increase in titers of CF antigen and plaque-forming units was seen from days 3 through 6 after infection; however, CF antigen was detected 24 hr after infection. The molecular weight of CF antigen was estimated by gel filtration to be greater than 1.5 X 10(7) daltons. Electrophoresis of CF antigens from five strains of human CMV (AD169, C87, Espilant [Esp.], Davis, and Towne) in a gradient polyacrylamide gel slab in the presence of sodium dodecyl sulfate revealed two specific polypeptides with molecular weights of 140,000 and 66,000 daltons, respectively. The smaller polypeptide was glycosylated. Preparations of CF antigen from murine CMV and herpes simplex virus type 1 contained polypeptides of 140,000 and 145,000 daltons, respectively. However, the polypeptide with a molecular weight of 66,000 daltons was seen only in preparations of human CMV.
Similar articles
-
Cytomegalovirus proteins: II. Polypeptide composition of cytomegalovirus complement-fixing antigen.J Med Virol. 1978;2(1):39-44. doi: 10.1002/jmv.1890020107. J Med Virol. 1978. PMID: 210253
-
Cytomegalovirus antigenic heterogeneity can cause false-negative results in indirect hemagglutination and complement fixation antibody assays.J Clin Microbiol. 1985 Nov;22(5):768-71. doi: 10.1128/jcm.22.5.768-771.1985. J Clin Microbiol. 1985. PMID: 2997271 Free PMC article.
-
Studies of human cytomegalovirus complement-fixing antigen.Virologie. 1983 Apr-Jun;34(2):119-29. Virologie. 1983. PMID: 6308886
-
Partial characterization of a soluble antigen preparation from cells infected with human cytomegalovirus: properties of antisera prepared to the antigen.J Immunol. 1975 May;114(5):1454-7. J Immunol. 1975. PMID: 164507
-
Viral polypeptides detected by a complement-dependent neutralizing murine monoclonal antibody to human cytomegalovirus.J Virol. 1985 Aug;55(2):274-80. doi: 10.1128/JVI.55.2.274-280.1985. J Virol. 1985. PMID: 2410626 Free PMC article.
Cited by
-
Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera.Infect Immun. 1982 Jun;36(3):933-42. doi: 10.1128/iai.36.3.933-942.1982. Infect Immun. 1982. PMID: 6284646 Free PMC article.
-
Production and characterization of monoclonal antibodies specific for a glycosylated polypeptide of human cytomegalovirus.J Clin Microbiol. 1983 Aug;18(2):331-43. doi: 10.1128/jcm.18.2.331-343.1983. J Clin Microbiol. 1983. PMID: 6194174 Free PMC article.
-
Confirmation of human cytomegalovirus by reverse passive hemagglutination with monoclonal antibodies reactive to the major glycosylated peptide (GP-66).J Clin Microbiol. 1986 Sep;24(3):474-7. doi: 10.1128/jcm.24.3.474-477.1986. J Clin Microbiol. 1986. PMID: 2428828 Free PMC article.
-
Assessment of human cytomegalovirus antibody detection techniques.Arch Virol. 1980;64(4):287-301. doi: 10.1007/BF01320614. Arch Virol. 1980. PMID: 6249241 Review. No abstract available.
-
Mitogenic activity in human embryonic fibroblasts early after infection by human cytomegalovirus.Infect Immun. 1982 Oct;38(1):375-9. doi: 10.1128/iai.38.1.375-379.1982. Infect Immun. 1982. PMID: 6292097 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources